-
-
-
-
-
-
-
Edgewise Therapeutics (EWTX) PT Raised to $45 at JPMorgan on 2026 Catalysts
-
-
-
-
-
-
-
Edgewise Therapeutics, Inc. (EWTX) Misses Q4 EPS by 3c
-
-
-
-
-
-
-
RBC Capital on Biotech Shares: 'Company-Specific Volatility For Quality Names May Be Overdone'
-
-
-
-
-
-
-
RBC Capital on Edgewise Therapeutics (EWTX): ' We Would Be Buyers on Weakness'
-
-
-
-
-
-
-
Edgewise Therapeutics Inc. (EWTX) April 20, April 21, April 22 and May 15 puts active as share price down 21%
-
-
-
-
-
-
-
Scotiabank Starts Edgewise Therapeutics (EWTX) at Sector Outperform
-
-
-
-
-
-
-
Biopharma 2025 Preview: 'Piper Sandler Sees Lots of Upside Opportunity'
-
415,021 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

